Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

Pfizer

Status: Completed

Conditions: Psoriasis; Arthritis, Psoriatic; Skin Diseases, Papulosquamous

Treatments: Drug: Etanercept

Study type: Observational

Funder types: Industry

Identifiers

NCT00293722

B1801127

0881A6-102064

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and effectiveness of etanercept under usual care settings in patients with PsA treated by rheumatologists.

Full description

Non-interventional study: subjects to be selected according to the usual clinical practice of their physician

Enrollment: 1,308 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of psoriatic arthritis

Exclusion criteria

• Sepsis or risk for sepsis,
• Acute infection,
• Hypersensitivity against Etanercept

Trial design

1,308 participants in 1 patient group

Patients with Psoriatic Arthritis

Treatment:

Drug: Etanercept